Search Results

There are 17362 results for: content related to: Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome

  1. You have free access to this content
    Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

    Intervention Review

    The Cochrane Library

    Richard P Mattick, Courtney Breen, Jo Kimber and Marina Davoli

    Published Online : 6 FEB 2014, DOI: 10.1002/14651858.CD002207.pub4

  2. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

    The Milbank Quarterly

    Volume 93, Issue 3, September 2015, Pages: 561–583, BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL and ANDREW W. DICK

    Article first published online : 8 SEP 2015, DOI: 10.1111/1468-0009.12137

  3. Buprenorphine for the management of opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 8 JUL 2009, DOI: 10.1002/14651858.CD002025.pub4

  4. Buprenorphine for treating cancer pain

    Intervention Review

    The Cochrane Library

    Mia Schmidt-Hansen, Nathan Bromham, Mark Taubert, Stephanie Arnold and Jennifer S Hilgart

    Published Online : 31 MAR 2015, DOI: 10.1002/14651858.CD009596.pub4

  5. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers

    Addiction

    Volume 105, Issue 4, April 2010, Pages: 709–718, Sandra D. Comer, Maria A. Sullivan, Suzanne K. Vosburg, Jeanne Manubay, Leslie Amass, Ziva D. Cooper, Phillip Saccone and Herbert D. Kleber

    Article first published online : 10 MAR 2010, DOI: 10.1111/j.1360-0443.2009.02843.x

    Corrected by:

    Erratum

    Vol. 105, Issue 7, 1322, Article first published online: 8 JUN 2010

  6. Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose-Escalation Trials

    The Journal of Clinical Pharmacology

    Volume 46, Issue 2, February 2006, Pages: 179–192, Dr Domenic A. Ciraulo, Dr Robert J. Hitzemann, Dr Eugene Somoza, Dr Clifford M. Knapp, Dr John Rotrosen, Dr Ofra Sarid-Segal, Ms Ann Marie Ciraulo, Dr David J. Greenblatt and Dr C. Nora Chiang

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270005284192

  7. The clinical use of buprenorphine in opiate addiction: evidence and practice

    Acta Neuropsychiatrica

    Volume 16, Issue 5, October 2004, Pages: 246–274, Fergus D. Law, Judy S. Myles, Mark R. C. Daglish and David J. Nutt

    Article first published online : 11 FEB 2005, DOI: 10.1111/j.0924-2708.2004.00095.x

  8. You have free access to this content
    Post-marketing Surveillance of Methadone and Buprenorphine in the United States

    Pain Medicine

    Volume 11, Issue 7, July 2010, Pages: 1078–1091, Nabarun Dasgupta, Elise J. Bailey, Theodore Cicero, James Inciardi, Mark Parrino, Andrew Rosenblum and Richard C. Dart

    Article first published online : 8 JUN 2010, DOI: 10.1111/j.1526-4637.2010.00877.x

  9. Buprenorphine in Maintenance Treatment: Experience among Italian Physicians in Drug Addiction Centers

    The American Journal on Addictions

    Volume 19, Issue 3, May-June 2010, Pages: 222–230, Gianluca Quaglio, Cristian Pattaro, Gilberto Gerra, Paolo Mezzelani, Linda Montanari, Don C. Des Jarlais and Fabio Lugoboni

    Article first published online : 2 APR 2010, DOI: 10.1111/j.1521-0391.2010.00040.x

  10. “Sub is a weird drug:” A web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms

    The American Journal on Addictions

    Volume 24, Issue 5, August 2015, Pages: 403–409, Raminta Daniulaityte, Robert Carlson, Gregory Brigham, Delroy Cameron and Amit Sheth

    Article first published online : 25 MAY 2015, DOI: 10.1111/ajad.12213

  11. Buprenorphine

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 514–526, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch28

  12. Correlations of Maternal Buprenorphine Dose, Buprenorphine, and Metabolite Concentrations in Meconium With Neonatal Outcomes

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 604–612, SL Kacinko, HE Jones, RE Johnson, RE Choo and MA Huestis

    Article first published online : 13 AUG 2008, DOI: 10.1038/clpt.2008.156

  13. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses

    Veterinary Anaesthesia and Analgesia

    Volume 42, Issue 1, January 2015, Pages: 17–29, Emma J Love, Ludovic Pelligand, Polly M Taylor, Joanna C Murrell and John W Sear

    Article first published online : 16 APR 2014, DOI: 10.1111/vaa.12165

  14. Buprenorphine-Based Regimens and Methadone for the Medical Management of Opioid Dependence: Selecting the Appropriate Drug for Treatment

    The American Journal on Addictions

    Volume 19, Issue 6, November-December 2010, Pages: 557–568, Icro Maremmani and Gilberto Gerra

    Article first published online : 21 SEP 2010, DOI: 10.1111/j.1521-0391.2010.00086.x

  15. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine

    European Journal of Pain

    Volume 13, Issue 3, March 2009, Pages: 219–230, Hans G. Kress

    Article first published online : 9 JAN 2012, DOI: 10.1016/j.ejpain.2008.04.011

  16. Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile

    Pain Practice

    Volume 10, Issue 5, September/October 2010, Pages: 428–450, Joseph Pergolizzi, Anna Maria Aloisi, Albert Dahan, Joerg Filitz, Richard Langford, Rudolf Likar, Sebastiano Mercadante, Bart Morlion, Robert B. Raffa, Rainer Sabatowski, Paola Sacerdote, Luis M. Torres and Avi A. Weinbroum

    Article first published online : 17 MAY 2010, DOI: 10.1111/j.1533-2500.2010.00378.x

  17. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 7, July 2015, Pages: 670–680, Chee M. Ng, Erin Dombrowsky, Hopi Lin, Michelle E. Erlich, David E. Moody, Jeffrey S. Barrett and Walter K. Kraft

    Article first published online : 14 JUL 2015, DOI: 10.1002/phar.1610

  18. You have free access to this content
    The clinical analgesic efficacy of buprenorphine

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 6, December 2014, Pages: 577–583, R. B. Raffa, M. Haidery, H.-M. Huang, K. Kalladeen, D. E. Lockstein, H. Ono, M. J. Shope, O. A. Sowunmi, J. K. Tran and J. V. Pergolizzi Jr

    Article first published online : 29 JUL 2014, DOI: 10.1111/jcpt.12196

  19. You have free access to this content
    Buprenorphine: An Analgesic with an Expanding Role in the Treatment of Opioid Addiction

    CNS Drug Reviews

    Volume 8, Issue 4, December 2002, Pages: 377–390, Susan E. Robinson

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2002.tb00235.x

  20. The history of the development of buprenorphine as an addiction therapeutic

    Annals of the New York Academy of Sciences

    Volume 1248, Issue 1, February 2012, Pages: 124–139, Nancy D. Campbell and Anne M. Lovell

    Article first published online : 18 JAN 2012, DOI: 10.1111/j.1749-6632.2011.06352.x